Form 8-K - Current report:
SEC Accession No. 0001213900-25-068190
Filing Date
2025-07-28
Accepted
2025-07-28 15:58:46
Documents
14
Period of Report
2025-07-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0250489-8k_inmed.htm   iXBRL 8-K 28275
2 NEWS RELEASE, DATED JULY 28, 2025 ea025048901ex99-1_inmed.htm EX-99.1 23198
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-25-068190.txt   230461

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20250728.xsd EX-101.SCH 3020
5 XBRL LABEL FILE inm-20250728_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE inm-20250728_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0250489-8k_inmed_htm.xml XML 3671
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 251155460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)